Industry Research Reports
Home > Reports > Pharma & Healthcare > Tacrolimus- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Tacrolimus- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for Tacrolimus was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
The North American market for Tacrolimus was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Tacrolimus was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Tacrolimus was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Tacrolimus market include GSK, Abbott, Roche Pharma, Novartis, Mylan, Squibb, Astellas, Aarti Group, Takeda, Huapont Pharma, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Tacrolimus, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Tacrolimus market size, estimations, and forecasts are presented in terms of sales volume (K MT) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Tacrolimus.
Market Segmentation
By Company
- GSK
- Abbott
- Roche Pharma
- Novartis
- Mylan
- Squibb
- Astellas
- Aarti Group
- Takeda
- Huapont Pharma
- Senju Pharmaceutical
- Guike Pharmaceutical
- Tecoland
- Sandoz
- ScinoPharm
- RPG Life Science
- Suzhou Pharmaceutical Technology
- Accura Pharmaceuticals
- Fujisawa Pharmaceutical
- Sichuan Med-Shine Pharmaceutical
- Sinopharm Chuankang Pharmaceutical
- Yamanouchi Pharmaceutical
- Zhongmei Huadong Pharmaceutical
- Hisun Pharmaceutical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Tacrolimus Capsules
- Tacrolimus Ointment
- Tacrolimus Injection
Segment by Application
- Hospitals
- Clinics
- Other
Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Tacrolimus manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Tacrolimus sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Tacrolimus sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Market Overview
1.1 Tacrolimus Product Introduction
1.2 Global Tacrolimus Market Size Forecast
1.2.1 Global Tacrolimus Sales Value (2021–2032)
1.2.2 Global Tacrolimus Sales Volume (2021–2032)
1.2.3 Global Tacrolimus Sales Price (2021–2032)
1.3 Tacrolimus Market Trends & Drivers
1.3.1 Tacrolimus Industry Trends
1.3.2 Tacrolimus Market Drivers & Opportunities
1.3.3 Tacrolimus Market Challenges
1.3.4 Tacrolimus Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Tacrolimus Players Revenue Ranking (2025)
2.2 Global Tacrolimus Revenue by Company (2021–2026)
2.3 Global Tacrolimus Sales Volume Ranking of Players (2025)
2.4 Global Tacrolimus Sales Volume by Company (2021–2026)
2.5 Global Tacrolimus Average Price by Company (2021–2026)
2.6 Key Manufacturers Tacrolimus Manufacturing Base and Headquarters
2.7 Key Manufacturers Tacrolimus Product Offerings
2.8 Key Manufacturers Start of Mass Production of Tacrolimus
2.9 Tacrolimus Market Competitive Analysis
2.9.1 Tacrolimus Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Tacrolimus Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Tacrolimus revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Tacrolimus Market Classification
3.1 Introduction by Type
3.1.1 Tacrolimus Capsules
3.1.2 Tacrolimus Ointment
3.1.3 Tacrolimus Injection
3.1.4 Global Tacrolimus Sales Value by Type
3.1.4.1 Global Tacrolimus Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Tacrolimus Sales Value, by Type (2021–2032)
3.1.4.3 Global Tacrolimus Sales Value, by Type (%), 2021–2032
3.1.5 Global Tacrolimus Sales Volume by Type
3.1.5.1 Global Tacrolimus Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Tacrolimus Sales Volume, by Type (2021–2032)
3.1.5.3 Global Tacrolimus Sales Volume, by Type (%), 2021–2032
3.1.6 Global Tacrolimus Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Other
4.2 Global Tacrolimus Sales Value by Application
4.2.1 Global Tacrolimus Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Tacrolimus Sales Value, by Application (2021–2032)
4.2.3 Global Tacrolimus Sales Value, by Application (%), 2021–2032
4.3 Global Tacrolimus Sales Volume by Application
4.3.1 Global Tacrolimus Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Tacrolimus Sales Volume, by Application (2021–2032)
4.3.3 Global Tacrolimus Sales Volume, by Application (%), 2021–2032
4.4 Global Tacrolimus Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Tacrolimus Sales Value by Region
5.1.1 Global Tacrolimus Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Tacrolimus Sales Value by Region (2021–2026)
5.1.3 Global Tacrolimus Sales Value by Region (2027–2032)
5.1.4 Global Tacrolimus Sales Value by Region (%), 2021–2032
5.2 Global Tacrolimus Sales Volume by Region
5.2.1 Global Tacrolimus Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Tacrolimus Sales Volume by Region (2021–2026)
5.2.3 Global Tacrolimus Sales Volume by Region (2027–2032)
5.2.4 Global Tacrolimus Sales Volume by Region (%), 2021–2032
5.3 Global Tacrolimus Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Tacrolimus Sales Value, 2021–2032
5.4.2 North America Tacrolimus Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Tacrolimus Sales Value, 2021–2032
5.5.2 Europe Tacrolimus Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Tacrolimus Sales Value, 2021–2032
5.6.2 Asia Pacific Tacrolimus Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Tacrolimus Sales Value, 2021–2032
5.7.2 South America Tacrolimus Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Tacrolimus Sales Value, 2021–2032
5.8.2 Middle East & Africa Tacrolimus Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Tacrolimus Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Tacrolimus Sales Value and Sales Volume
6.2.1 Key Countries/Regions Tacrolimus Sales Value, 2021–2032
6.2.2 Key Countries/Regions Tacrolimus Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Tacrolimus Sales Value, 2021–2032
6.3.2 United States Tacrolimus Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Tacrolimus Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Tacrolimus Sales Value, 2021–2032
6.4.2 Europe Tacrolimus Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Tacrolimus Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Tacrolimus Sales Value, 2021–2032
6.5.2 China Tacrolimus Sales Value by Type (%), 2025 vs 2032
6.5.3 China Tacrolimus Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Tacrolimus Sales Value, 2021–2032
6.6.2 Japan Tacrolimus Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Tacrolimus Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Tacrolimus Sales Value, 2021–2032
6.7.2 South Korea Tacrolimus Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Tacrolimus Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Tacrolimus Sales Value, 2021–2032
6.8.2 Southeast Asia Tacrolimus Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Tacrolimus Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Tacrolimus Sales Value, 2021–2032
6.9.2 India Tacrolimus Sales Value by Type (%), 2025 vs 2032
6.9.3 India Tacrolimus Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 GSK
7.1.1 GSK Company Information
7.1.2 GSK Introduction and Business Overview
7.1.3 GSK Tacrolimus Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 GSK Tacrolimus Product Offerings
7.1.5 GSK Recent Developments
7.2 Abbott
7.2.1 Abbott Company Information
7.2.2 Abbott Introduction and Business Overview
7.2.3 Abbott Tacrolimus Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Abbott Tacrolimus Product Offerings
7.2.5 Abbott Recent Developments
7.3 Roche Pharma
7.3.1 Roche Pharma Company Information
7.3.2 Roche Pharma Introduction and Business Overview
7.3.3 Roche Pharma Tacrolimus Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Roche Pharma Tacrolimus Product Offerings
7.3.5 Roche Pharma Recent Developments
7.4 Novartis
7.4.1 Novartis Company Information
7.4.2 Novartis Introduction and Business Overview
7.4.3 Novartis Tacrolimus Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Novartis Tacrolimus Product Offerings
7.4.5 Novartis Recent Developments
7.5 Mylan
7.5.1 Mylan Company Information
7.5.2 Mylan Introduction and Business Overview
7.5.3 Mylan Tacrolimus Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Mylan Tacrolimus Product Offerings
7.5.5 Mylan Recent Developments
7.6 Squibb
7.6.1 Squibb Company Information
7.6.2 Squibb Introduction and Business Overview
7.6.3 Squibb Tacrolimus Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Squibb Tacrolimus Product Offerings
7.6.5 Squibb Recent Developments
7.7 Astellas
7.7.1 Astellas Company Information
7.7.2 Astellas Introduction and Business Overview
7.7.3 Astellas Tacrolimus Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Astellas Tacrolimus Product Offerings
7.7.5 Astellas Recent Developments
7.8 Aarti Group
7.8.1 Aarti Group Company Information
7.8.2 Aarti Group Introduction and Business Overview
7.8.3 Aarti Group Tacrolimus Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Aarti Group Tacrolimus Product Offerings
7.8.5 Aarti Group Recent Developments
7.9 Takeda
7.9.1 Takeda Company Information
7.9.2 Takeda Introduction and Business Overview
7.9.3 Takeda Tacrolimus Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Takeda Tacrolimus Product Offerings
7.9.5 Takeda Recent Developments
7.10 Huapont Pharma
7.10.1 Huapont Pharma Company Information
7.10.2 Huapont Pharma Introduction and Business Overview
7.10.3 Huapont Pharma Tacrolimus Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Huapont Pharma Tacrolimus Product Offerings
7.10.5 Huapont Pharma Recent Developments
7.11 Senju Pharmaceutical
7.11.1 Senju Pharmaceutical Company Information
7.11.2 Senju Pharmaceutical Introduction and Business Overview
7.11.3 Senju Pharmaceutical Tacrolimus Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Senju Pharmaceutical Tacrolimus Product Offerings
7.11.5 Senju Pharmaceutical Recent Developments
7.12 Guike Pharmaceutical
7.12.1 Guike Pharmaceutical Company Information
7.12.2 Guike Pharmaceutical Introduction and Business Overview
7.12.3 Guike Pharmaceutical Tacrolimus Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Guike Pharmaceutical Tacrolimus Product Offerings
7.12.5 Guike Pharmaceutical Recent Developments
7.13 Tecoland
7.13.1 Tecoland Company Information
7.13.2 Tecoland Introduction and Business Overview
7.13.3 Tecoland Tacrolimus Sales, Revenue, Price and Gross Margin (2021–2026)
7.13.4 Tecoland Tacrolimus Product Offerings
7.13.5 Tecoland Recent Developments
7.14 Sandoz
7.14.1 Sandoz Company Information
7.14.2 Sandoz Introduction and Business Overview
7.14.3 Sandoz Tacrolimus Sales, Revenue, Price and Gross Margin (2021–2026)
7.14.4 Sandoz Tacrolimus Product Offerings
7.14.5 Sandoz Recent Developments
7.15 ScinoPharm
7.15.1 ScinoPharm Company Information
7.15.2 ScinoPharm Introduction and Business Overview
7.15.3 ScinoPharm Tacrolimus Sales, Revenue, Price and Gross Margin (2021–2026)
7.15.4 ScinoPharm Tacrolimus Product Offerings
7.15.5 ScinoPharm Recent Developments
7.16 RPG Life Science
7.16.1 RPG Life Science Company Information
7.16.2 RPG Life Science Introduction and Business Overview
7.16.3 RPG Life Science Tacrolimus Sales, Revenue, Price and Gross Margin (2021–2026)
7.16.4 RPG Life Science Tacrolimus Product Offerings
7.16.5 RPG Life Science Recent Developments
7.17 Suzhou Pharmaceutical Technology
7.17.1 Suzhou Pharmaceutical Technology Company Information
7.17.2 Suzhou Pharmaceutical Technology Introduction and Business Overview
7.17.3 Suzhou Pharmaceutical Technology Tacrolimus Sales, Revenue, Price and Gross Margin (2021–2026)
7.17.4 Suzhou Pharmaceutical Technology Tacrolimus Product Offerings
7.17.5 Suzhou Pharmaceutical Technology Recent Developments
7.18 Accura Pharmaceuticals
7.18.1 Accura Pharmaceuticals Company Information
7.18.2 Accura Pharmaceuticals Introduction and Business Overview
7.18.3 Accura Pharmaceuticals Tacrolimus Sales, Revenue, Price and Gross Margin (2021–2026)
7.18.4 Accura Pharmaceuticals Tacrolimus Product Offerings
7.18.5 Accura Pharmaceuticals Recent Developments
7.19 Fujisawa Pharmaceutical
7.19.1 Fujisawa Pharmaceutical Company Information
7.19.2 Fujisawa Pharmaceutical Introduction and Business Overview
7.19.3 Fujisawa Pharmaceutical Tacrolimus Sales, Revenue, Price and Gross Margin (2021–2026)
7.19.4 Fujisawa Pharmaceutical Tacrolimus Product Offerings
7.19.5 Fujisawa Pharmaceutical Recent Developments
7.20 Sichuan Med-Shine Pharmaceutical
7.20.1 Sichuan Med-Shine Pharmaceutical Company Information
7.20.2 Sichuan Med-Shine Pharmaceutical Introduction and Business Overview
7.20.3 Sichuan Med-Shine Pharmaceutical Tacrolimus Sales, Revenue, Price and Gross Margin (2021–2026)
7.20.4 Sichuan Med-Shine Pharmaceutical Tacrolimus Product Offerings
7.20.5 Sichuan Med-Shine Pharmaceutical Recent Developments
7.21 Sinopharm Chuankang Pharmaceutical
7.21.1 Sinopharm Chuankang Pharmaceutical Company Information
7.21.2 Sinopharm Chuankang Pharmaceutical Introduction and Business Overview
7.21.3 Sinopharm Chuankang Pharmaceutical Tacrolimus Sales, Revenue, Price and Gross Margin (2021–2026)
7.21.4 Sinopharm Chuankang Pharmaceutical Tacrolimus Product Offerings
7.21.5 Sinopharm Chuankang Pharmaceutical Recent Developments
7.22 Yamanouchi Pharmaceutical
7.22.1 Yamanouchi Pharmaceutical Company Information
7.22.2 Yamanouchi Pharmaceutical Introduction and Business Overview
7.22.3 Yamanouchi Pharmaceutical Tacrolimus Sales, Revenue, Price and Gross Margin (2021–2026)
7.22.4 Yamanouchi Pharmaceutical Tacrolimus Product Offerings
7.22.5 Yamanouchi Pharmaceutical Recent Developments
7.23 Zhongmei Huadong Pharmaceutical
7.23.1 Zhongmei Huadong Pharmaceutical Company Information
7.23.2 Zhongmei Huadong Pharmaceutical Introduction and Business Overview
7.23.3 Zhongmei Huadong Pharmaceutical Tacrolimus Sales, Revenue, Price and Gross Margin (2021–2026)
7.23.4 Zhongmei Huadong Pharmaceutical Tacrolimus Product Offerings
7.23.5 Zhongmei Huadong Pharmaceutical Recent Developments
7.24 Hisun Pharmaceutical
7.24.1 Hisun Pharmaceutical Company Information
7.24.2 Hisun Pharmaceutical Introduction and Business Overview
7.24.3 Hisun Pharmaceutical Tacrolimus Sales, Revenue, Price and Gross Margin (2021–2026)
7.24.4 Hisun Pharmaceutical Tacrolimus Product Offerings
7.24.5 Hisun Pharmaceutical Recent Developments
8 Industry Chain Analysis
8.1 Tacrolimus Industrial Chain
8.2 Tacrolimus Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Tacrolimus Sales Model
8.5.2 Sales Channels
8.5.3 Tacrolimus Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. Tacrolimus Market Trends
Table 2. Tacrolimus Market Drivers & Opportunities
Table 3. Tacrolimus Market Challenges
Table 4. Tacrolimus Market Restraints
Table 5. Global Tacrolimus Revenue by Company (US$ Million), 2021–2026
Table 6. Global Tacrolimus Revenue Market Share by Company (2021–2026)
Table 7. Global Tacrolimus Sales Volume by Company (K MT), 2021–2026
Table 8. Global Tacrolimus Sales Volume Market Share by Company (2021–2026)
Table 9. Global Market Tacrolimus Price by Company (USD/MT), 2021–2026
Table 10. Key Manufacturers Tacrolimus Manufacturing Base and Headquarters
Table 11. Key Manufacturers Tacrolimus Product Type
Table 12. Key Manufacturers Start of Mass Production of Tacrolimus
Table 13. Global Tacrolimus Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Tacrolimus revenue, 2025
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Tacrolimus Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Tacrolimus Sales Value by Type (US$ Million), 2021–2026
Table 18. Global Tacrolimus Sales Value by Type (US$ Million), 2027–2032
Table 19. Global Tacrolimus Sales Market Share in Value by Type (2021–2026)
Table 20. Global Tacrolimus Sales Market Share in Value by Type (2027–2032)
Table 21. Global Tacrolimus Sales Volume by Type: 2021 vs 2025 vs 2032 (K MT)
Table 22. Global Tacrolimus Sales Volume by Type (K MT), 2021–2026
Table 23. Global Tacrolimus Sales Volume by Type (K MT), 2027–2032
Table 24. Global Tacrolimus Sales Market Share in Volume by Type (2021–2026)
Table 25. Global Tacrolimus Sales Market Share in Volume by Type (2027–2032)
Table 26. Global Tacrolimus Price by Type (USD/MT), 2021–2026
Table 27. Global Tacrolimus Price by Type (USD/MT), 2027–2032
Table 28. Global Tacrolimus Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global Tacrolimus Sales Value by Application (US$ Million), 2021–2026
Table 30. Global Tacrolimus Sales Value by Application (US$ Million), 2027–2032
Table 31. Global Tacrolimus Sales Market Share in Value by Application (2021–2026)
Table 32. Global Tacrolimus Sales Market Share in Value by Application (2027–2032)
Table 33. Global Tacrolimus Sales Volume by Application: 2021 vs 2025 vs 2032 (K MT)
Table 34. Global Tacrolimus Sales Volume by Application (K MT), 2021–2026
Table 35. Global Tacrolimus Sales Volume by Application (K MT), 2027–2032
Table 36. Global Tacrolimus Sales Market Share in Volume by Application (2021–2026)
Table 37. Global Tacrolimus Sales Market Share in Volume by Application (2027–2032)
Table 38. Global Tacrolimus Price by Application (USD/MT), 2021–2026
Table 39. Global Tacrolimus Price by Application (USD/MT), 2027–2032
Table 40. Global Tacrolimus Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 41. Global Tacrolimus Sales Value by Region (US$ Million), 2021–2026
Table 42. Global Tacrolimus Sales Value by Region (US$ Million), 2027–2032
Table 43. Global Tacrolimus Sales Value by Region (%), 2021–2026
Table 44. Global Tacrolimus Sales Value by Region (%), 2027–2032
Table 45. Global Tacrolimus Sales Volume by Region (K MT): 2021 vs 2025 vs 2032
Table 46. Global Tacrolimus Sales Volume by Region (K MT), 2021–2026
Table 47. Global Tacrolimus Sales Volume by Region (K MT), 2027–2032
Table 48. Global Tacrolimus Sales Volume by Region (%), 2021–2026
Table 49. Global Tacrolimus Sales Volume by Region (%), 2027–2032
Table 50. Global Tacrolimus Average Price by Region (USD/MT), 2021–2026
Table 51. Global Tacrolimus Average Price by Region (USD/MT), 2027–2032
Table 52. Key Countries/Regions Tacrolimus Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 53. Key Countries/Regions Tacrolimus Sales Value, (US$ Million), 2021–2026
Table 54. Key Countries/Regions Tacrolimus Sales Value, (US$ Million), 2027–2032
Table 55. Key Countries/Regions Tacrolimus Sales Volume, (K MT), 2021–2026
Table 56. Key Countries/Regions Tacrolimus Sales Volume, (K MT), 2027–2032
Table 57. GSK Company Information
Table 58. GSK Introduction and Business Overview
Table 59. GSK Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 60. GSK Tacrolimus Product Offerings
Table 61. GSK Recent Developments
Table 62. Abbott Company Information
Table 63. Abbott Introduction and Business Overview
Table 64. Abbott Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 65. Abbott Tacrolimus Product Offerings
Table 66. Abbott Recent Developments
Table 67. Roche Pharma Company Information
Table 68. Roche Pharma Introduction and Business Overview
Table 69. Roche Pharma Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 70. Roche Pharma Tacrolimus Product Offerings
Table 71. Roche Pharma Recent Developments
Table 72. Novartis Company Information
Table 73. Novartis Introduction and Business Overview
Table 74. Novartis Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 75. Novartis Tacrolimus Product Offerings
Table 76. Novartis Recent Developments
Table 77. Mylan Company Information
Table 78. Mylan Introduction and Business Overview
Table 79. Mylan Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 80. Mylan Tacrolimus Product Offerings
Table 81. Mylan Recent Developments
Table 82. Squibb Company Information
Table 83. Squibb Introduction and Business Overview
Table 84. Squibb Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 85. Squibb Tacrolimus Product Offerings
Table 86. Squibb Recent Developments
Table 87. Astellas Company Information
Table 88. Astellas Introduction and Business Overview
Table 89. Astellas Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 90. Astellas Tacrolimus Product Offerings
Table 91. Astellas Recent Developments
Table 92. Aarti Group Company Information
Table 93. Aarti Group Introduction and Business Overview
Table 94. Aarti Group Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 95. Aarti Group Tacrolimus Product Offerings
Table 96. Aarti Group Recent Developments
Table 97. Takeda Company Information
Table 98. Takeda Introduction and Business Overview
Table 99. Takeda Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 100. Takeda Tacrolimus Product Offerings
Table 101. Takeda Recent Developments
Table 102. Huapont Pharma Company Information
Table 103. Huapont Pharma Introduction and Business Overview
Table 104. Huapont Pharma Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 105. Huapont Pharma Tacrolimus Product Offerings
Table 106. Huapont Pharma Recent Developments
Table 107. Senju Pharmaceutical Company Information
Table 108. Senju Pharmaceutical Introduction and Business Overview
Table 109. Senju Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 110. Senju Pharmaceutical Tacrolimus Product Offerings
Table 111. Senju Pharmaceutical Recent Developments
Table 112. Guike Pharmaceutical Company Information
Table 113. Guike Pharmaceutical Introduction and Business Overview
Table 114. Guike Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 115. Guike Pharmaceutical Tacrolimus Product Offerings
Table 116. Guike Pharmaceutical Recent Developments
Table 117. Tecoland Company Information
Table 118. Tecoland Introduction and Business Overview
Table 119. Tecoland Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 120. Tecoland Tacrolimus Product Offerings
Table 121. Tecoland Recent Developments
Table 122. Sandoz Company Information
Table 123. Sandoz Introduction and Business Overview
Table 124. Sandoz Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 125. Sandoz Tacrolimus Product Offerings
Table 126. Sandoz Recent Developments
Table 127. ScinoPharm Company Information
Table 128. ScinoPharm Introduction and Business Overview
Table 129. ScinoPharm Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 130. ScinoPharm Tacrolimus Product Offerings
Table 131. ScinoPharm Recent Developments
Table 132. RPG Life Science Company Information
Table 133. RPG Life Science Introduction and Business Overview
Table 134. RPG Life Science Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 135. RPG Life Science Tacrolimus Product Offerings
Table 136. RPG Life Science Recent Developments
Table 137. Suzhou Pharmaceutical Technology Company Information
Table 138. Suzhou Pharmaceutical Technology Introduction and Business Overview
Table 139. Suzhou Pharmaceutical Technology Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 140. Suzhou Pharmaceutical Technology Tacrolimus Product Offerings
Table 141. Suzhou Pharmaceutical Technology Recent Developments
Table 142. Accura Pharmaceuticals Company Information
Table 143. Accura Pharmaceuticals Introduction and Business Overview
Table 144. Accura Pharmaceuticals Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 145. Accura Pharmaceuticals Tacrolimus Product Offerings
Table 146. Accura Pharmaceuticals Recent Developments
Table 147. Fujisawa Pharmaceutical Company Information
Table 148. Fujisawa Pharmaceutical Introduction and Business Overview
Table 149. Fujisawa Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 150. Fujisawa Pharmaceutical Tacrolimus Product Offerings
Table 151. Fujisawa Pharmaceutical Recent Developments
Table 152. Sichuan Med-Shine Pharmaceutical Company Information
Table 153. Sichuan Med-Shine Pharmaceutical Introduction and Business Overview
Table 154. Sichuan Med-Shine Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 155. Sichuan Med-Shine Pharmaceutical Tacrolimus Product Offerings
Table 156. Sichuan Med-Shine Pharmaceutical Recent Developments
Table 157. Sinopharm Chuankang Pharmaceutical Company Information
Table 158. Sinopharm Chuankang Pharmaceutical Introduction and Business Overview
Table 159. Sinopharm Chuankang Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 160. Sinopharm Chuankang Pharmaceutical Tacrolimus Product Offerings
Table 161. Sinopharm Chuankang Pharmaceutical Recent Developments
Table 162. Yamanouchi Pharmaceutical Company Information
Table 163. Yamanouchi Pharmaceutical Introduction and Business Overview
Table 164. Yamanouchi Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 165. Yamanouchi Pharmaceutical Tacrolimus Product Offerings
Table 166. Yamanouchi Pharmaceutical Recent Developments
Table 167. Zhongmei Huadong Pharmaceutical Company Information
Table 168. Zhongmei Huadong Pharmaceutical Introduction and Business Overview
Table 169. Zhongmei Huadong Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 170. Zhongmei Huadong Pharmaceutical Tacrolimus Product Offerings
Table 171. Zhongmei Huadong Pharmaceutical Recent Developments
Table 172. Hisun Pharmaceutical Company Information
Table 173. Hisun Pharmaceutical Introduction and Business Overview
Table 174. Hisun Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 175. Hisun Pharmaceutical Tacrolimus Product Offerings
Table 176. Hisun Pharmaceutical Recent Developments
Table 177. Key Raw Materials Lists
Table 178. Key Suppliers of Raw Materials Lists
Table 179. Tacrolimus Downstream Customers
Table 180. Tacrolimus Distributors List
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
List of Figures
Figure 1. Tacrolimus Product Picture
Figure 2. Global Tacrolimus Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Tacrolimus Sales Value (US$ Million), 2021–2032
Figure 4. Global Tacrolimus Sales Volume (K MT), 2021–2032
Figure 5. Global Tacrolimus Sales Price (USD/MT), 2021–2032
Figure 6. Tacrolimus Report Years Considered
Figure 7. Global Tacrolimus Players Revenue Ranking (US$ Million), 2025
Figure 8. Global Tacrolimus Sales Volume Ranking of Players (K MT), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Tacrolimus Revenue in 2025
Figure 10. Tacrolimus Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. Tacrolimus Capsules Picture
Figure 12. Tacrolimus Ointment Picture
Figure 13. Tacrolimus Injection Picture
Figure 14. Global Tacrolimus Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Tacrolimus Sales Value Market Share by Type, 2025 & 2032
Figure 16. Global Tacrolimus Sales Volume by Type (K MT), 2021 vs 2025 vs 2032
Figure 17. Global Tacrolimus Sales Volume Market Share by Type, 2025 & 2032
Figure 18. Global Tacrolimus Price by Type (USD/MT), 2021–2032
Figure 19. Product Picture of Hospitals
Figure 20. Product Picture of Clinics
Figure 21. Product Picture of Other
Figure 22. Global Tacrolimus Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Tacrolimus Sales Value Market Share by Application, 2025 & 2032
Figure 24. Global Tacrolimus Sales Volume by Application (K MT), 2021 vs 2025 vs 2032
Figure 25. Global Tacrolimus Sales Volume Market Share by Application, 2025 & 2032
Figure 26. Global Tacrolimus Price by Application (USD/MT), 2021–2032
Figure 27. North America Tacrolimus Sales Value (US$ Million), 2021–2032
Figure 28. North America Tacrolimus Sales Value by Country (%), 2025 vs 2032
Figure 29. Europe Tacrolimus Sales Value (US$ Million), 2021–2032
Figure 30. Europe Tacrolimus Sales Value by Country (%), 2025 vs 2032
Figure 31. Asia Pacific Tacrolimus Sales Value (US$ Million), 2021–2032
Figure 32. Asia Pacific Tacrolimus Sales Value by Region (%), 2025 vs 2032
Figure 33. South America Tacrolimus Sales Value (US$ Million), 2021–2032
Figure 34. South America Tacrolimus Sales Value by Country (%), 2025 vs 2032
Figure 35. Middle East & Africa Tacrolimus Sales Value (US$ Million), 2021–2032
Figure 36. Middle East & Africa Tacrolimus Sales Value by Country (%), 2025 vs 2032
Figure 37. Key Countries/Regions Tacrolimus Sales Value (%), 2021–2032
Figure 38. Key Countries/Regions Tacrolimus Sales Volume (%), 2021–2032
Figure 39. United States Tacrolimus Sales Value (US$ Million), 2021–2032
Figure 40. United States Tacrolimus Sales Value by Type (%), 2025 vs 2032
Figure 41. United States Tacrolimus Sales Value by Application (%), 2025 vs 2032
Figure 42. Europe Tacrolimus Sales Value (US$ Million), 2021–2032
Figure 43. Europe Tacrolimus Sales Value by Type (%), 2025 vs 2032
Figure 44. Europe Tacrolimus Sales Value by Application (%), 2025 vs 2032
Figure 45. China Tacrolimus Sales Value (US$ Million), 2021–2032
Figure 46. China Tacrolimus Sales Value by Type (%), 2025 vs 2032
Figure 47. China Tacrolimus Sales Value by Application (%), 2025 vs 2032
Figure 48. Japan Tacrolimus Sales Value (US$ Million), 2021–2032
Figure 49. Japan Tacrolimus Sales Value by Type (%), 2025 vs 2032
Figure 50. Japan Tacrolimus Sales Value by Application (%), 2025 vs 2032
Figure 51. South Korea Tacrolimus Sales Value (US$ Million), 2021–2032
Figure 52. South Korea Tacrolimus Sales Value by Type (%), 2025 vs 2032
Figure 53. South Korea Tacrolimus Sales Value by Application (%), 2025 vs 2032
Figure 54. Southeast Asia Tacrolimus Sales Value (US$ Million), 2021–2032
Figure 55. Southeast Asia Tacrolimus Sales Value by Type (%), 2025 vs 2032
Figure 56. Southeast Asia Tacrolimus Sales Value by Application (%), 2025 vs 2032
Figure 57. India Tacrolimus Sales Value (US$ Million), 2021–2032
Figure 58. India Tacrolimus Sales Value by Type (%), 2025 vs 2032
Figure 59. India Tacrolimus Sales Value by Application (%), 2025 vs 2032
Figure 60. Tacrolimus Industrial Chain
Figure 61. Tacrolimus Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Related Reports
Global Tacrolimus Market Research Report 2024
The global Tacrolimus market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-05
Pages: 115
USD 2900.00
(Single User License)
Tacrolimus - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Tacrolimus was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-24
Pages: 167
USD 3950.00
(Single User License)
Global Tacrolimus Market Insights, Forecast to 2030
The global Tacrolimus market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-22
Pages: 127
USD 4900.00
(Single User License)
Global Tacrolimus Market Research Report 2025
The global market for Tacrolimus was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-25
Pages: 108
USD 2900.00
(Single User License)
Tacrolimus- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tacrolimus was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 151
USD 3950.00
(Single User License)
Global Tacrolimus Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Tacrolimus market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 117
USD 4250.00
(Single User License)
Global Tacrolimus Market Research Report 2026
The global Tacrolimus market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-28
Pages: 147
USD 2900.00
(Single User License)
Global Tacrolimus Market Research Report 2024
The global Tacrolimus market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-05
Pages: 115
USD 2900.00 (Single User License)Tacrolimus - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Tacrolimus was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-24
Pages: 167
USD 3950.00 (Single User License)Global Tacrolimus Market Insights, Forecast to 2030
The global Tacrolimus market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-22
Pages: 127
USD 4900.00 (Single User License)Global Tacrolimus Market Research Report 2025
The global market for Tacrolimus was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-25
Pages: 108
USD 2900.00 (Single User License)Tacrolimus- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tacrolimus was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 151
USD 3950.00 (Single User License)Global Tacrolimus Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Tacrolimus market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 117
USD 4250.00 (Single User License)Global Tacrolimus Market Research Report 2026
The global Tacrolimus market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-28
Pages: 147
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
Market Segmentation
Why This Report?
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research